Cargando…

Biology of Cholangiocytes: From Bench to Bedside

Cholangiocytes, the lining epithelial cells in bile ducts, are an important subset of liver cells. They are activated by endogenous and exogenous stimuli and are involved in the modification of bile volume and composition. They are also involved in damaging and repairing the liver. Cholangiocytes ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Kyo-Sang, Lim, Woo Taek, Choi, Ho Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003190/
https://www.ncbi.nlm.nih.gov/pubmed/27563020
http://dx.doi.org/10.5009/gnl16033
_version_ 1782450620818522112
author Yoo, Kyo-Sang
Lim, Woo Taek
Choi, Ho Soon
author_facet Yoo, Kyo-Sang
Lim, Woo Taek
Choi, Ho Soon
author_sort Yoo, Kyo-Sang
collection PubMed
description Cholangiocytes, the lining epithelial cells in bile ducts, are an important subset of liver cells. They are activated by endogenous and exogenous stimuli and are involved in the modification of bile volume and composition. They are also involved in damaging and repairing the liver. Cholangiocytes have many functions including bile production. They are also involved in transport processes that regulate the volume and composition of bile. Cholangiocytes undergo proliferation and cell death under a variety of conditions. Cholangiocytes have functional and morphological heterogenecity. The immunobiology of cholangiocytes is important, particularly for understanding biliary disease. Secretion of different proinflammatory mediators, cytokines, and chemokines suggests the major role that cholangiocytes play in inflammatory reactions. Furthermore, paracrine secretion of growth factors and peptides mediates extensive cross-talk with other liver cells, including hepatocytes, stellate cells, stem cells, subepithelial myofibroblasts, endothelial cells, and inflammatory cells. Cholangiopathy refers to a category of chronic liver diseases whose primary disease target is the cholangiocyte. Cholangiopathy usually results in end-stage liver disease requiring liver transplant. We summarize the biology of cholangiocytes and redefine the concept of cholangiopathy. We also discuss the recent progress that has been made in understanding the pathogenesis of cholangiopathy and how such progress has influenced therapy.
format Online
Article
Text
id pubmed-5003190
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-50031902016-09-09 Biology of Cholangiocytes: From Bench to Bedside Yoo, Kyo-Sang Lim, Woo Taek Choi, Ho Soon Gut Liver Review Cholangiocytes, the lining epithelial cells in bile ducts, are an important subset of liver cells. They are activated by endogenous and exogenous stimuli and are involved in the modification of bile volume and composition. They are also involved in damaging and repairing the liver. Cholangiocytes have many functions including bile production. They are also involved in transport processes that regulate the volume and composition of bile. Cholangiocytes undergo proliferation and cell death under a variety of conditions. Cholangiocytes have functional and morphological heterogenecity. The immunobiology of cholangiocytes is important, particularly for understanding biliary disease. Secretion of different proinflammatory mediators, cytokines, and chemokines suggests the major role that cholangiocytes play in inflammatory reactions. Furthermore, paracrine secretion of growth factors and peptides mediates extensive cross-talk with other liver cells, including hepatocytes, stellate cells, stem cells, subepithelial myofibroblasts, endothelial cells, and inflammatory cells. Cholangiopathy refers to a category of chronic liver diseases whose primary disease target is the cholangiocyte. Cholangiopathy usually results in end-stage liver disease requiring liver transplant. We summarize the biology of cholangiocytes and redefine the concept of cholangiopathy. We also discuss the recent progress that has been made in understanding the pathogenesis of cholangiopathy and how such progress has influenced therapy. Editorial Office of Gut and Liver 2016-09 2016-09-15 /pmc/articles/PMC5003190/ /pubmed/27563020 http://dx.doi.org/10.5009/gnl16033 Text en Copyright © 2016 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Yoo, Kyo-Sang
Lim, Woo Taek
Choi, Ho Soon
Biology of Cholangiocytes: From Bench to Bedside
title Biology of Cholangiocytes: From Bench to Bedside
title_full Biology of Cholangiocytes: From Bench to Bedside
title_fullStr Biology of Cholangiocytes: From Bench to Bedside
title_full_unstemmed Biology of Cholangiocytes: From Bench to Bedside
title_short Biology of Cholangiocytes: From Bench to Bedside
title_sort biology of cholangiocytes: from bench to bedside
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003190/
https://www.ncbi.nlm.nih.gov/pubmed/27563020
http://dx.doi.org/10.5009/gnl16033
work_keys_str_mv AT yookyosang biologyofcholangiocytesfrombenchtobedside
AT limwootaek biologyofcholangiocytesfrombenchtobedside
AT choihosoon biologyofcholangiocytesfrombenchtobedside